Why the study?
Does polycystic ovary syndrome increase the prevalence or incidence of impaired glucose tolerance, type 2 diabetes, and metabolic syndrome in women?
Population
Women with and without polycystic ovary syndrome (PCOS) from 35 included studies
Comparison
Polycystic ovary syndrome (PCOS) (exposure) vs Women without PCOS
Design
Meta-analysis
Authors
Loading...
Supports metabolic screening in women with PCOS; reinforces and quantifies cardiometabolic risk associations.
Does polycystic ovary syndrome increase the prevalence or incidence of impaired glucose tolerance, type 2 diabetes, and metabolic syndrome in women?
Women with PCOS have a significantly elevated prevalence of impaired glucose tolerance, type 2 diabetes, and metabolic syndrome, highlighting the need for metabolic screening in this population.
Moran et al. (2010) studied this question.
Synapse has enriched 4 closely related papers on similar clinical questions. Consider them for comparative context: